Key Insights

Highlights

Success Rate

92% trial completion (above average)

Research Maturity

67 completed trials (37% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.3%

6 terminated out of 181 trials

Success Rate

91.8%

+5.3% vs benchmark

Late-Stage Pipeline

18%

32 trials in Phase 3/4

Results Transparency

10%

7 of 67 completed with results

Key Signals

7 with results92% success

Data Visualizations

Phase Distribution

106Total
Not Applicable (55)
P 1 (7)
P 2 (12)
P 3 (18)
P 4 (14)

Trial Status

Completed67
Unknown59
Recruiting22
Not Yet Recruiting12
Active Not Recruiting10
Terminated6

Trial Success Rate

91.8%

Benchmark: 86.5%

Based on 67 completed trials

Clinical Trials (181)

Showing 20 of 20 trials
NCT04864626Active Not Recruiting

Study of the Impact on the Evolution of the Disease in the Medium Term of the Implementation of a System of Extended Follow-up by Telephone Interview of Patients With an Eating Disorder Organized by the Nurses of the Eating Disorder Referral Center

NCT06401772Not ApplicableRecruiting

The Effectiveness and Safety of Body Posture in Preventing Postoperative Recurrence for Chronic Subdural Hematoma

NCT05797246Phase 2Active Not Recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT07030686Recruiting

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

NCT07505316Not ApplicableCompleted

Holmium Laser Versus Cold Knife Treatment in Urethral Strictures

NCT07509346Phase 2Not Yet Recruiting

Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive Cholangitis

NCT07478705Not ApplicableNot Yet Recruiting

Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and Imaging

NCT06508138Phase 1Enrolling By Invitation

Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection

NCT06379321Recruiting

Evaluation of Outcomes of the Triathlon Hinge Knee (THK) System

NCT07424092Phase 2Not Yet Recruiting

Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors

NCT05557474Recruiting

Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

NCT07379489Not Yet Recruiting

Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

NCT07350824Not ApplicableNot Yet Recruiting

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

NCT07347977Not ApplicableNot Yet Recruiting

Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk

NCT07167381Not ApplicableRecruiting

xDRIVE for Florida-based Cancer Patients

NCT06621407Not ApplicableRecruiting

A National Study Examining the Most Effective Drainage Method After Burr Hole Evacuation of Chronic Subdural Hematoma

NCT04838613Phase 3Completed

Study of Diagnostic Performance of [18F]CTT1057 in BCR

NCT06245915Phase 1Active Not Recruiting

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

NCT05331599Active Not Recruiting

Recurrence Markers, Cognitive Burden and Neurobiological Homeostasis in Late-Life Depression

NCT05617755Phase 1Active Not Recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

Scroll to load more

Research Network

Activity Timeline